SAVARINO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 52.483
AS - Asia 5.016
NA - Nord America 3.800
SA - Sud America 422
AF - Africa 79
OC - Oceania 8
Totale 61.808
Nazione #
IT - Italia 51.662
US - Stati Uniti d'America 3.506
SG - Singapore 2.060
CN - Cina 1.248
VN - Vietnam 720
BD - Bangladesh 479
FR - Francia 424
BR - Brasile 247
HK - Hong Kong 172
CA - Canada 124
FI - Finlandia 81
DE - Germania 80
MX - Messico 72
AR - Argentina 68
IN - India 63
GB - Regno Unito 57
JP - Giappone 54
IQ - Iraq 40
NL - Olanda 33
CH - Svizzera 27
EC - Ecuador 27
ID - Indonesia 23
CO - Colombia 21
ES - Italia 20
JM - Giamaica 20
CL - Cile 19
VE - Venezuela 19
TR - Turchia 16
CR - Costa Rica 15
IE - Irlanda 14
RU - Federazione Russa 14
TH - Thailandia 14
ZA - Sudafrica 14
NP - Nepal 13
PH - Filippine 13
PE - Perù 12
JO - Giordania 11
MA - Marocco 11
NI - Nicaragua 11
SA - Arabia Saudita 11
KE - Kenya 10
PL - Polonia 10
GT - Guatemala 9
HN - Honduras 8
MY - Malesia 8
SV - El Salvador 8
TW - Taiwan 8
UA - Ucraina 8
AU - Australia 7
KR - Corea 7
LT - Lituania 7
PK - Pakistan 7
SE - Svezia 7
TT - Trinidad e Tobago 7
DZ - Algeria 6
OM - Oman 6
TN - Tunisia 6
BH - Bahrain 5
PY - Paraguay 5
SI - Slovenia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
SN - Senegal 4
AT - Austria 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
IR - Iran 3
PA - Panama 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
BZ - Belize 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
ME - Montenegro 2
MN - Mongolia 2
NG - Nigeria 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
TG - Togo 2
UY - Uruguay 2
YT - Mayotte 2
AL - Albania 1
AO - Angola 1
AW - Aruba 1
Totale 61.776
Città #
Genova 33.728
Genoa 10.466
Rapallo 4.096
Vado Ligure 2.886
Singapore 934
San Jose 932
Lauterbourg 400
Ashburn 337
New York 227
Ho Chi Minh City 221
Beijing 185
Hong Kong 172
Hanoi 160
Santa Clara 114
Los Angeles 98
Council Bluffs 84
Helsinki 77
Frankfurt am Main 65
Bordighera 62
Orem 58
Rome 56
Dallas 51
Tokyo 46
Mexico City 44
Buffalo 42
Milan 41
Chicago 40
Da Nang 33
Atlanta 29
Phoenix 27
Tianjin 27
San Francisco 26
Toronto 26
Amsterdam 25
Haiphong 25
Naples 25
Zurich 25
Montreal 22
Philadelphia 22
St Louis 22
Bologna 21
São Paulo 21
Chennai 20
Hải Dương 16
Guangzhou 15
Houston 15
Kingston 15
Boardman 14
Brooklyn 14
Denver 14
Baghdad 13
Dublin 13
Mumbai 13
Boston 12
Florence 12
Jacksonville 12
Memphis 12
Poplar 12
Washington 12
Amman 11
Charlotte 11
Queens 11
Shanghai 11
City of London 10
Quito 10
Rio de Janeiro 10
San José 10
Seattle 10
The Bronx 10
Biên Hòa 9
Curitiba 9
Guayaquil 9
Managua 9
Nairobi 9
Pittsburgh 9
Warsaw 9
Bangkok 8
Can Tho 8
Cardiff 8
Las Vegas 8
London 8
Miami 8
Ninh Bình 8
Padua 8
Palermo 8
Quảng Ngãi 8
San Salvador 8
Bari 7
Cleveland 7
Des Moines 7
Dhaka 7
Fortaleza 7
Greensboro 7
Lima 7
Louisville 7
Manchester 7
Modena 7
Omaha 7
Richmond 7
Sacramento 7
Totale 56.578
Nome #
Proton pump inhibitors: use and misuse in the clinical setting 247
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 246
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 245
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 233
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis 225
5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for “best evidence”? 224
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 223
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 223
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 216
Positive PET in a patient with esophageal leiomyoma. 214
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 212
Time pattern of gastric acidity in Barrett's esophagus 210
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 209
Measurement of oro-caecal transit time by magnetic resonance imaging. 209
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 206
13C-mixed triglyceride (13C-MTG) breath-test (BT) in Cystic Fibrosis (CF). 205
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 204
Are proton pump inhibitors really so dangerous? 203
A safety review of proton pump inhibitors to treat acid-related digestive diseases 202
Circadian monitoring of gastric juice mutagenicity. 201
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 200
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 200
Barrett's esophagus in 2016: From pathophysiology to treatment 199
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 198
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study 198
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up 197
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 197
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. 196
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 196
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. 196
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 196
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 194
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 194
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease 193
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 192
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 191
Breath tests to assess alcoholic liver disease. 191
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 189
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication 189
Ilaprazole for the treatment of gastro-esophageal reflux 188
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 187
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. 185
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 185
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 185
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 185
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 183
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy 181
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. 181
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 180
A comparison of five maintenance therapies for reflux esophagitis 180
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 180
24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. 179
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 178
Circadian reduction of chromium in the gastric environment. 178
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. 177
The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up 177
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 176
Can artificial neural networks be beneficial in diagnosing gastro-oesophageal reflux disease? 176
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 175
Burden of illness in Italian patients with gastro-oesophageal reflux disease. 174
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 174
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 174
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 173
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 173
Acid and gastric metaplasia in the duodenum 172
Starry Liver: An Unexpected Diagnosis 171
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 171
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 171
A Nodule, is a Nodule, is a Nodule: May Alpha-fetoprotein Make the Difference? 170
Anti-TNF Antibodies For Prevention of Crohn's Disease Recurrence After Surgery: More Than An Hope. 170
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 170
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 169
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease. 169
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 169
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma 168
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 168
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 168
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 167
Adalimumab trough levels and response to biological treatment in patients with Inflammatory Bowel Disease: a useful cut-off In clinical practice. 167
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 166
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 166
Assessment of Intestinal Permeability Using Sugar Probes: Influence of Urinary Volume 165
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 165
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens 163
13C-octanoic ac. Breath test: neural network analysis of 13C excretion data 163
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 162
External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis 162
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. 162
Letter: Biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease 162
Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives 162
An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic hepatitis C virus infection and advanced liver disease 161
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. 161
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 161
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab. 161
The appropriate use of proton-pump inhibitors 161
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 160
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease 160
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 159
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 159
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 159
Totale 18.487
Categoria #
all - tutte 191.526
article - articoli 178.392
book - libri 521
conference - conferenze 2.802
curatela - curatele 0
other - altro 9.491
patent - brevetti 0
selected - selezionate 0
volume - volumi 320
Totale 383.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.241 161 297 378 744 235 408 388 1.125 212 497 177 619
2022/20234.913 530 265 60 424 947 890 6 379 886 32 437 57
2023/20242.217 117 319 50 224 185 396 129 100 138 39 142 378
2024/20257.016 275 599 263 452 959 718 570 1.066 279 293 695 847
2025/202612.730 1.420 298 927 1.117 1.408 1.476 2.042 553 810 1.184 660 835
2026/20271.303 1.303 0 0 0 0 0 0 0 0 0 0 0
Totale 62.434